Showing results (211-220 of 308) with videos related to

Sort By:
Pageof 31
Journal of Neuroimmunology|May 12, 2019
B cell depletion with ublituximab reshapes the T cell profile in multiple sclerosis patientsAmy E Lovett-Racke, Matthew Gormley, Yue Liu, et al.
Digital Health|May 19, 2023
Development and usability testing of your MS questionnaire: A patient-based digital tool to monitor symptoms of multiple sclerosisGavin Giovannoni, Enrique Alvarez, Ellen Tutton, et al.
MDM Policy & Practice|November 1, 2019
A Novel Tool to Improve Shared Decision Making and Adherence in Multiple Sclerosis: Development and Preliminary TestingNananda Col, Enrique Alvarez, Vicky Springmann, et al.
Multiple Sclerosis and Related Disorders|November 6, 2023
Implementing Shared Decision-Making for Multiple Sclerosis: The MS-SUPPORT ToolNananda F Col, Andrew J Solomon, Enrique Alvarez, et al.
Cancer Biology & Therapy|May 27, 2005
Recombinant semaphorin 6A-1 ectodomain inhibits in vivo growth factor and tumor cell line-induced angiogenesisMohanraj Dhanabal, Frank Wu, Enrique Alvarez, et al.
Medrxiv : the Preprint Server for Health Sciences|February 23, 2026
AI-powered Gradient Echo Plural Contrast Imaging (AI-GEPCI) - a Comprehensive Multiparametric Neurological Protocol from a Single MRI ScanJeramy Lewis, Manu S Goyal, Gregory F Wu, et al.
European Journal of Immunology|April 7, 2011
Conditional deletion of SLP-76 in mature T cells abrogates peripheral immune responsesGregory F Wu, Evann Corbo, Michelle Schmidt, et al.
Journal of Magnetic Resonance Imaging : JMRI|May 2, 2026
AI-Powered Gradient Echo Plural Contrast Imaging (AI-GEPCI)-A Comprehensive Neurological Protocol From a Single MRI ScanJeramy Lewis, Manu S Goyal, Gregory F Wu, et al.
Neurology and Therapy|March 5, 2026
Efficacy of Ublituximab in People with Highly Active Relapsing Multiple SclerosisHans-Peter Hartung, Derrick Robertson, Lawrence Steinman, et al.
Neurology. Clinical Practice|August 25, 2018
Discontinuation and comparative effectiveness of dimethyl fumarate and fingolimod in 2 centersBrandi Vollmer, Daniel Ontaneda, Anasua Bandyopadhyay, et al.
Pageof 31